ZIOPHARM Oncology Garners $120,000,000 New Financing

  • Feed Type
  • Date
  • Company Name
    ZIOPHARM Oncology
  • Mailing Address
    1 First Ave. Boston, MA 02129 USA
  • Company Description
    Operations were initiated in January 2004 with the strategy of in-licensing proprietary drug candidate families with prior related-molecule efficacy in human cancer that would be efficiently and effectively developed and commercialized by a very experienced management team supported by prominent clinicians and medical advisors.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 1 investor participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy